FluMos-v2 (VRCFLUMOS0116-00-VP Mosaic Hexavalent Influenza Vaccine)

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FluMos-v2 (VRCFLUMOS0116-00-VP Mosaic Hexavalent Influenza Vaccine), covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults [Phase 1]

See pricing